LBP AM’s Edwards Lifesciences EW Stock Holding History

LBP AM’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.52M	Sell	118,839 -9,863	-8%	-$813K	0.13%	159
2025 Q4	$11M	Buy	128,702 +107,330	+502%	+$8.81M	0.13%	158
2025 Q3	$1.66M	Buy	21,372 +4,271	+25%	+$334K	0.02%	304
2025 Q2	$1.34M	Buy	+17,101	New	+$1.28M	0.02%	302
2024 Q3	–	Sell	-24,099	Closed	-$2.23M	–	380
2024 Q2	$2.23M	Sell	24,099 -74	-0.3%	-$6.55K	0.09%	151
2024 Q1	$2.31M	Sell	24,173 -81	-0.3%	-$6.8K	0.09%	159
2023 Q4	$1.85M	Sell	24,254 -24,563	-50%	-$1.71M	0.04%	272
2023 Q3	$3.38M	Buy	48,817 +18,797	+63%	+$1.51M	0.08%	228
2023 Q2	$2.83M	Sell	30,020 -17,164	-36%	-$1.49M	0.07%	213
2023 Q1	$3.9M	Sell	47,184 -1,626	-3%	-$128K	0.1%	192
2022 Q4	$3.64M	Buy	+48,810	New	+$3.76M	0.1%	195

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

LBP AM's EW Position: Q1 2026 in Review

LBP AM reduced its Edwards Lifesciences (EW) stake by 7.7% in Q1 2026, selling an estimated $813K and leaving 118,839 shares worth $9.52M. The position accounts for 0.13% of the portfolio, ranked #159.

LBP AM first reported a position in EW in Q4 2022 and has held it in 11 quarters since. The position peaked at $11M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

LBP AM held 118,839 shares of Edwards Lifesciences worth $9.52M as of Q1 2026.
LBP AM sold 9,863 Edwards Lifesciences shares in Q1 2026, an estimated $813K.
Edwards Lifesciences made up 0.13% of LBP AM's portfolio in Q1 2026, its #159 holding.
LBP AM first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 11 quarters since.
LBP AM's Edwards Lifesciences position peaked at $11M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.